Genome Mining-Guided Discovery of Two New Depsides from Talaromyces sp. HDN1820200.

IF 4.9 2区 医学 Q1 CHEMISTRY, MEDICINAL
Marine Drugs Pub Date : 2025-03-18 DOI:10.3390/md23030130
Xiao Zhang, Luyang Liu, Jiani Huang, Xingtao Ren, Guojian Zhang, Qian Che, Dehai Li, Tianjiao Zhu
{"title":"Genome Mining-Guided Discovery of Two New Depsides from <i>Talaromyces</i> sp. HDN1820200.","authors":"Xiao Zhang, Luyang Liu, Jiani Huang, Xingtao Ren, Guojian Zhang, Qian Che, Dehai Li, Tianjiao Zhu","doi":"10.3390/md23030130","DOIUrl":null,"url":null,"abstract":"<p><p>Depsides and their derivatives are a class of polyketides predominantly found in fungal extracts. Herein, a silent nonreducing polyketide synthase (TalsA)-containing gene cluster, which was identified from the Antarctic sponge-derived fungus <i>Talaromyces</i> sp. HDN1820200, was successfully activated through heterologous expression in <i>Aspergillus nidulans</i>. This activation led to the production of two novel depsides, talaronic acid A (<b>1</b>) and B (<b>2</b>), alongside three known compounds (<b>3</b>-<b>5</b>). The further co-expression of TalsA with the decarboxylase (TalsF) demonstrated that it could convert <b>2</b> into its decarboxylated derivative <b>1</b>. The structural elucidation of these compounds was achieved using comprehensive 1D and 2D-NMR spectroscopy, which was complemented by HR-MS analysis. Talaronic acids A and B were firstly reported heterodimers of 3-methylorsellinic acid (3-MOA) and 5-methylorsellinic acid (5-MOA). All isolated compounds (<b>1</b>-<b>5</b>) were tested for their anti-inflammatory potential. Notably, compounds <b>1</b> and <b>2</b> exhibited anti-inflammatory activity comparable to that of the positive control. These results further enrich the structural class of depside natural products.</p>","PeriodicalId":18222,"journal":{"name":"Marine Drugs","volume":"23 3","pages":""},"PeriodicalIF":4.9000,"publicationDate":"2025-03-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11944171/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Marine Drugs","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.3390/md23030130","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"CHEMISTRY, MEDICINAL","Score":null,"Total":0}
引用次数: 0

Abstract

Depsides and their derivatives are a class of polyketides predominantly found in fungal extracts. Herein, a silent nonreducing polyketide synthase (TalsA)-containing gene cluster, which was identified from the Antarctic sponge-derived fungus Talaromyces sp. HDN1820200, was successfully activated through heterologous expression in Aspergillus nidulans. This activation led to the production of two novel depsides, talaronic acid A (1) and B (2), alongside three known compounds (3-5). The further co-expression of TalsA with the decarboxylase (TalsF) demonstrated that it could convert 2 into its decarboxylated derivative 1. The structural elucidation of these compounds was achieved using comprehensive 1D and 2D-NMR spectroscopy, which was complemented by HR-MS analysis. Talaronic acids A and B were firstly reported heterodimers of 3-methylorsellinic acid (3-MOA) and 5-methylorsellinic acid (5-MOA). All isolated compounds (1-5) were tested for their anti-inflammatory potential. Notably, compounds 1 and 2 exhibited anti-inflammatory activity comparable to that of the positive control. These results further enrich the structural class of depside natural products.

基因组挖掘引导下Talaromyces sp. HDN1820200两个新深度的发现。
深度及其衍生物是一类聚酮,主要存在于真菌提取物中。本研究通过对南极海绵状真菌Talaromyces sp. HDN1820200的异源表达,成功激活了含沉默非还原性聚酮合成酶(TalsA)的基因簇。这种激活导致了两种新的深度,塔拉酸A(1)和B(2),以及三种已知化合物(3-5)的产生。TalsA与脱羧酶(TalsF)的进一步共表达表明,TalsA可以将2转化为其脱羧衍生物1。这些化合物的结构是通过综合的一维和二维核磁共振光谱来实现的,并辅以HR-MS分析。Talaronic酸A和B是首次报道的3-甲基苯甲酸(3-MOA)和5-甲基苯甲酸(5-MOA)异源二聚体。所有分离的化合物(1-5)均被测试其抗炎潜能。值得注意的是,化合物1和2表现出与阳性对照相当的抗炎活性。这些结果进一步丰富了深部天然产物的结构类别。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Marine Drugs
Marine Drugs 医学-医药化学
CiteScore
9.60
自引率
14.80%
发文量
671
审稿时长
1 months
期刊介绍: Marine Drugs (ISSN 1660-3397) publishes reviews, regular research papers and short notes on the research, development and production of drugs from the sea. Our aim is to encourage scientists to publish their experimental and theoretical research in as much detail as possible, particularly synthetic procedures and characterization information for bioactive compounds. There is no restriction on the length of the experimental section.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信